1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Aerosolized Dornase Alfa (DNase I) for the Treatment of Severe Respiratory Failure in COVID-19 : A Randomized Controlled Trial
- Contribution to journal › Article
- 2024
-
Mark
The benefits and drawbacks of home oxygen therapy for COPD : what’s next?
- Contribution to journal › Scientific review
-
Mark
Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Results of an International Randomized Controlled Trial (PEXIVAS)
- Contribution to journal › Article
- 2022
-
Mark
Peripheral Oxygen Saturation Facilitates Assessment of Respiratory Dysfunction in the Sequential Organ Failure Assessment Score with Implications for the Sepsis-3 Criteria
- Contribution to journal › Article
- 2021
-
Mark
Effects of red blood cell transfusions given to non-septic critically ill patients : a propensity score matched study
- Contribution to journal › Article
- 2020
-
Mark
Novel Biomarkes in Acute Respiratory Failure and Chronic Obstructive Pulmonary Disease.
(2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Mortality and morbidity of low-grade red blood cell transfusions in septic patients : a propensity score-matched observational study of a liberal transfusion strategy
- Contribution to journal › Article
- 2017
-
Mark
A nationwide structure for valid Long-Term oxygen therapy : 29-Year prospective data in Sweden
- Contribution to journal › Article
- 2013
-
Mark
Heparin binding protein in patients with acute respiratory failure treated with granulocyte colony-stimulating factor (filgrastim) - a prospective, placebo-controlled, double-blind study
- Contribution to journal › Article
- 2012
-
Mark
Hereditary myopathy with early respiratory failure associated with a mutation in A-band titin
- Contribution to journal › Article
